
Consumer Sentiment Sinks to 47.8 on Gas Prices, Trade Tensions
Preliminary UMich 47.8 missed all forecasts; year-ahead inflation expectations up to 4.6% on gas and tariffs.
Daily Digest
Daily Digest
Pomegra Briefs - Page 48 of 52
Short, sourced summaries of the biggest market stories - what happened, why it matters, the key numbers, and what to watch next

Preliminary UMich 47.8 missed all forecasts; year-ahead inflation expectations up to 4.6% on gas and tariffs.
Moderna (MRNA), already up 404% in 2026, gained 9% Friday on Phase 3 melanoma data and two FDA approvals.
UBS slashed NuScale (SMR) to Sell with a $6 target, citing $700M cash burn as rivals reach construction phase.

SpaceX (SPCX) rose 2% as CFO Bret Johnsen confirmed a new $1.11B-a-month AI hosting deal starting December.

Chewy (CHWY) is now 40% below its year-start price as JPMorgan cut its target to $24 on macro headwinds.

ExxonMobil (XOM) leads energy stocks higher as Brent crude above $107 pushes the 10-year yield toward 4.95%.
Amgen (AMGN) fell on pelacarsen's Phase 3 miss and a BMO Capital downgrade, pulling Eli Lilly down 2%.
Houthis seized Yemen's Mocha port and bombed Aramco (2222.SR), driving Brent to $107.63 and the Dow down 316.

HP Inc. (HPQ) hits a 52-week high after RBC Capital's $33 Sector Perform debut adds fuel to the AI-PC cycle.

Hewlett Packard Enterprise (HPE) extends gains as top analyst targets hit $88 on surging AI network orders.

Dell (DELL) hits a record high on RBC's $640 price target; $95B AI-server backlog signals multi-year growth.
WaFd (WAFD) shareholders will hold just 40.8% of the new $75B bank, set to trade on Nasdaq as EVBK.
Roivant Sciences (ROIV) shares soared as Pulmovant's mosliciguat cut PVR 56.3%, a PH-ILD trial record.

Dyne Therapeutics (DYN) plunged 23% as Novartis's Phase 3 DM1 failure sparked a J.P. Morgan $10 downgrade.
Reddit (RDDT) rose 6% Thursday as Piper Sandler data showed 18% annual user growth in August, the year's best.
Page 48 of 52 · 770 briefs